In Ohio, the Cleveland Clinic joined the Circulating Cell-free Genome Atlas, a national clinical trial that is looking for 7,000 cancer patients and 3,000 healthy patients in the U.S. Their goal is to analyze DNA and RNA in the blood and build a database that will help with detecting cancer early on when it is easier to cure. Researchers believe that using genome sequencing from blood samples could possibly replace x-rays for early cancer detection. Funded by a company in California, GRAIL, Inc., the project will be looking for molecule patterns in the blood for specific types of cancers.
Latest article
Dutch research envisions homes made from fungus
In The Netherlands, researchers at Utrecht University have submitted a paper detailing the potential for homes to be made out of fungus.
The group evaluates...
Living, programmable robots raise ethics concerns
In Boston, researchers have created living, programmable organisms that could one day have widespread applications, including cleaning microplastics from the oceans.
Dubbed xenobots by their...
Itaconix and Nouryon terminate chelates deal
In the United Kingdom, Itaconix and chemical giant Nouryon have mutually agreed to terminate an agreement in which Nouryon exclusively distributes Itaconix’s biobased chelating...